HEADER RECEPTOR 28-AUG-06 2J4A TITLE HUMAN THYROID HORMONE RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX TITLE 2 WITH KB131084 COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYROID HORMONE RECEPTOR BETA-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 209-461; COMPND 5 SYNONYM: THYROID HORMONE RECEPTOR BETA LBD; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS NUCLEAR PROTEIN, DISEASE MUTATION, NUCLEAR RECEPTOR, ZINC, RECEPTOR, KEYWDS 2 DEAFNESS, ZINC-FINGER, DNA-BINDING, TRANSCRIPTION REGULATION, KEYWDS 3 TRANSCRIPTION, ALTERNATIVE SPLICING, LIGAND BINDING DOMAIN, KEYWDS 4 POLYMORPHISM, METAL-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR M.FARNEGARDH REVDAT 3 24-JUL-19 2J4A 1 REMARK REVDAT 2 24-FEB-09 2J4A 1 VERSN REVDAT 1 25-SEP-07 2J4A 0 JRNL AUTH K.KOEHLER,S.GORDON,P.BRANDT,B.CARLSSON,A.BACKSBRO-SAEDI, JRNL AUTH 2 T.APELQVIST,P.AGBACK,G.J.GROVER,W.NELSON,M.GRYNFARB, JRNL AUTH 3 M.FARNEGARDH,S.REHNMARK,J.MALM JRNL TITL THYROID RECEPTOR LIGANDS. 6. A HIGH AFFINITY "DIRECT JRNL TITL 2 ANTAGONIST" SELECTIVE FOR THE THYROID HORMONE RECEPTOR. JRNL REF J.MED.CHEM. V. 49 6635 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17154490 JRNL DOI 10.1021/JM060521I REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 14450 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 725 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2209 REMARK 3 BIN R VALUE (WORKING SET) : 0.2680 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 100 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1965 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.26000 REMARK 3 B22 (A**2) : -10.57100 REMARK 3 B33 (A**2) : 5.31100 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.28 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.000 REMARK 3 BOND ANGLES (DEGREES) : 0.000 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 57.70 REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.820 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.410 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.190 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.820 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 35.87 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : OEF.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : OEF.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2J4A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1290029754. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9330 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14513 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.45 M AMMONIUMSULFATE, 100 MMTRIS REMARK 280 PH8.0, 100MM NDSB REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 33.60400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 33.60400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.60600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.71100 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.60600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.71100 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.60400 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.60600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 53.71100 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 33.60400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.60600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 53.71100 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2099 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASN 331 TO SER REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 209 REMARK 465 HIS A 210 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 299 CG CD OE1 OE2 REMARK 470 GLU A 333 CG CD OE1 OE2 REMARK 470 LYS A 394 CG CD CE NZ REMARK 470 THR A 448 OG1 CG2 REMARK 470 ASP A 461 CA C O CB CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 238 126.75 -37.65 REMARK 500 CYS A 388 57.63 -90.30 REMARK 500 VAL A 414 131.45 -172.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OEF A1461 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BSX RELATED DB: PDB REMARK 900 STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR -COACTIVATOR REMARK 900 INTERACTIONS REMARK 900 RELATED ID: 1N46 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND- BINDING DOMAINCOMPLEXED REMARK 900 WITH A POTENT SUBTYPE -SELECTIVE THYROMIMETIC REMARK 900 RELATED ID: 1NAX RELATED DB: PDB REMARK 900 THYROID RECEPTOR BETA1 IN COMPLEX WITH A BETA-SELECTIVELIGAND REMARK 900 RELATED ID: 1NQ0 RELATED DB: PDB REMARK 900 TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE ANDREDUCED REMARK 900 COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY INTHE NTERMINAL LBD REMARK 900 RELATED ID: 1NQ1 RELATED DB: PDB REMARK 900 TR RECEPTOR MUTATIONS CONFERRING HORMONE RESISTANCE ANDREDUCED REMARK 900 COREPRESSOR RELEASE EXHIBIT DECREASED STABILITY INTHE NTERMINAL LBD REMARK 900 RELATED ID: 1NQ2 RELATED DB: PDB REMARK 900 TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING REMARK 900 RELATED ID: 1NUO RELATED DB: PDB REMARK 900 TWO RTH MUTANTS WITH IMPAIRED HORMONE BINDING REMARK 900 RELATED ID: 1Q4X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN THYROID HORMONE RECEPTOR BETALBD IN REMARK 900 COMPLEX WITH SPECIFIC AGONIST GC-24 REMARK 900 RELATED ID: 1R6G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE THYROID HORMONE RECEPTOR BETALIGAND REMARK 900 BINDING DOMAIN IN COMPLEX WITH A BETA SELECTIVECOMPOUND REMARK 900 RELATED ID: 1XZX RELATED DB: PDB REMARK 900 THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS REMARK 900 RELATED ID: 1Y0X RELATED DB: PDB REMARK 900 THYROXINE-THYROID HORMONE RECEPTOR INTERACTIONS REMARK 900 RELATED ID: 2H6W RELATED DB: PDB REMARK 900 THYROID HORMONE RECEPTOR BOUND TO T3 REMARK 900 RELATED ID: 2NLL RELATED DB: PDB REMARK 900 RETINOID X RECEPTOR-THYROID HORMONE RECEPTOR DEOXYRIBONUCLEIC ACID- REMARK 900 BINDING DOMAIN HETERODIMER BOUND TO THYROID RESPONSE ELEMENT REMARK 900 DEOXYRIBONUCLEIC ACID DBREF 2J4A A 209 461 UNP P10828 THB1_HUMAN 209 461 SEQADV 2J4A SER A 331 UNP P10828 ASN 331 ENGINEERED MUTATION SEQRES 1 A 253 GLY HIS LYS PRO GLU PRO THR ASP GLU GLU TRP GLU LEU SEQRES 2 A 253 ILE LYS THR VAL THR GLU ALA HIS VAL ALA THR ASN ALA SEQRES 3 A 253 GLN GLY SER HIS TRP LYS GLN LYS ARG LYS PHE LEU PRO SEQRES 4 A 253 GLU ASP ILE GLY GLN ALA PRO ILE VAL ASN ALA PRO GLU SEQRES 5 A 253 GLY GLY LYS VAL ASP LEU GLU ALA PHE SER HIS PHE THR SEQRES 6 A 253 LYS ILE ILE THR PRO ALA ILE THR ARG VAL VAL ASP PHE SEQRES 7 A 253 ALA LYS LYS LEU PRO MET PHE CYS GLU LEU PRO CYS GLU SEQRES 8 A 253 ASP GLN ILE ILE LEU LEU LYS GLY CYS CYS MET GLU ILE SEQRES 9 A 253 MET SER LEU ARG ALA ALA VAL ARG TYR ASP PRO GLU SER SEQRES 10 A 253 GLU THR LEU THR LEU SER GLY GLU MET ALA VAL THR ARG SEQRES 11 A 253 GLY GLN LEU LYS ASN GLY GLY LEU GLY VAL VAL SER ASP SEQRES 12 A 253 ALA ILE PHE ASP LEU GLY MET SER LEU SER SER PHE ASN SEQRES 13 A 253 LEU ASP ASP THR GLU VAL ALA LEU LEU GLN ALA VAL LEU SEQRES 14 A 253 LEU MET SER SER ASP ARG PRO GLY LEU ALA CYS VAL GLU SEQRES 15 A 253 ARG ILE GLU LYS TYR GLN ASP SER PHE LEU LEU ALA PHE SEQRES 16 A 253 GLU HIS TYR ILE ASN TYR ARG LYS HIS HIS VAL THR HIS SEQRES 17 A 253 PHE TRP PRO LYS LEU LEU MET LYS VAL THR ASP LEU ARG SEQRES 18 A 253 MET ILE GLY ALA CYS HIS ALA SER ARG PHE LEU HIS MET SEQRES 19 A 253 LYS VAL GLU CYS PRO THR GLU LEU PHE PRO PRO LEU PHE SEQRES 20 A 253 LEU GLU VAL PHE GLU ASP HET OEF A1461 24 HETNAM OEF 3,5-DIBROMO-4-(3-ISOPROPYL-PHENOXY)BENZOIC ACID FORMUL 2 OEF C18 H18 BR2 O4 FORMUL 3 HOH *107(H2 O) HELIX 1 1 THR A 215 ASN A 233 1 19 HELIX 2 2 HIS A 238 ARG A 243 1 6 HELIX 3 3 ASP A 265 LYS A 288 1 24 HELIX 4 4 LEU A 290 GLU A 295 1 6 HELIX 5 5 PRO A 297 VAL A 319 1 23 HELIX 6 6 ARG A 338 GLY A 344 1 7 HELIX 7 7 GLY A 347 SER A 361 1 15 HELIX 8 8 ASP A 366 MET A 379 1 14 HELIX 9 9 CYS A 388 LYS A 411 1 24 HELIX 10 10 HIS A 416 CYS A 446 1 31 HELIX 11 11 PRO A 447 PHE A 451 5 5 HELIX 12 12 PRO A 452 GLU A 460 1 9 SHEET 1 AA 4 LYS A 244 PHE A 245 0 SHEET 2 AA 4 MET A 334 THR A 337 1 N ALA A 335 O LYS A 244 SHEET 3 AA 4 THR A 327 LEU A 330 -1 O LEU A 328 N VAL A 336 SHEET 4 AA 4 TYR A 321 ASP A 322 -1 N ASP A 322 O THR A 327 SITE 1 AC1 20 PHE A 272 THR A 273 ILE A 275 ILE A 276 SITE 2 AC1 20 ALA A 279 ARG A 282 MET A 310 MET A 313 SITE 3 AC1 20 ARG A 316 ARG A 320 LEU A 330 SER A 331 SITE 4 AC1 20 LEU A 341 GLY A 344 ILE A 353 HIS A 435 SITE 5 AC1 20 MET A 442 PHE A 455 HOH A2024 HOH A2027 CRYST1 77.212 107.422 67.208 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012951 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009309 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014879 0.00000